CME Group Inc (NASDAQ:CME) Expected to Post Quarterly Sales of $1.20 Billion

Share on StockTwits

Equities analysts expect that CME Group Inc (NASDAQ:CME) will report $1.20 billion in sales for the current fiscal quarter, Zacks reports. Four analysts have provided estimates for CME Group’s earnings. The highest sales estimate is $1.22 billion and the lowest is $1.18 billion. CME Group reported sales of $1.24 billion during the same quarter last year, which would suggest a negative year-over-year growth rate of 3.2%. The company is scheduled to announce its next earnings report on Thursday, February 13th.

On average, analysts expect that CME Group will report full-year sales of $4.92 billion for the current financial year, with estimates ranging from $4.91 billion to $4.94 billion. For the next fiscal year, analysts expect that the firm will post sales of $5.15 billion, with estimates ranging from $4.98 billion to $5.27 billion. Zacks Investment Research’s sales averages are a mean average based on a survey of sell-side research analysts that that provide coverage for CME Group.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, October 30th. The financial services provider reported $1.90 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.75 by $0.15. The business had revenue of $1.28 billion during the quarter, compared to the consensus estimate of $1.27 billion. CME Group had a return on equity of 9.54% and a net margin of 40.93%. The business’s quarterly revenue was up 41.3% on a year-over-year basis. During the same period in the prior year, the company posted $1.45 EPS.

CME has been the subject of several recent research reports. ValuEngine downgraded CME Group from a “buy” rating to a “hold” rating in a research note on Wednesday, October 2nd. Deutsche Bank reduced their price objective on CME Group from $248.00 to $245.00 and set a “buy” rating for the company in a research note on Wednesday, November 27th. Oppenheimer initiated coverage on CME Group in a research note on Monday, September 16th. They issued an “outperform” rating and a $234.00 price objective for the company. JPMorgan Chase & Co. reduced their price objective on CME Group from $183.00 to $173.00 and set an “underweight” rating for the company in a research note on Friday, December 6th. Finally, Citigroup increased their price objective on CME Group from $220.00 to $240.00 and gave the company a “buy” rating in a research note on Monday, October 21st. Three equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and six have issued a buy rating to the stock. CME Group has a consensus rating of “Hold” and a consensus price target of $207.42.

In other CME Group news, CEO Terrence A. Duffy sold 39,309 shares of the firm’s stock in a transaction on Thursday, December 12th. The stock was sold at an average price of $202.38, for a total value of $7,955,355.42. Following the completion of the sale, the chief executive officer now directly owns 46,684 shares of the company’s stock, valued at approximately $9,447,907.92. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Ronald A. Pankau sold 300 shares of the firm’s stock in a transaction on Thursday, November 7th. The stock was sold at an average price of $199.02, for a total value of $59,706.00. Following the completion of the sale, the director now directly owns 3,906 shares of the company’s stock, valued at $777,372.12. The disclosure for this sale can be found here. 1.20% of the stock is owned by company insiders.

Institutional investors and hedge funds have recently modified their holdings of the business. Advantage Investment Management LLC grew its holdings in shares of CME Group by 119.0% during the 2nd quarter. Advantage Investment Management LLC now owns 184 shares of the financial services provider’s stock worth $36,000 after purchasing an additional 100 shares during the period. Investec Asset Management North America Inc. boosted its holdings in CME Group by 6.5% during the 2nd quarter. Investec Asset Management North America Inc. now owns 4,950 shares of the financial services provider’s stock valued at $961,000 after acquiring an additional 300 shares during the period. Oakwood Capital Management LLC CA purchased a new position in CME Group during the 2nd quarter valued at about $5,792,000. Ibex Wealth Advisors purchased a new position in CME Group during the 2nd quarter valued at about $152,000. Finally, AGF Investments LLC boosted its holdings in CME Group by 107.4% during the 2nd quarter. AGF Investments LLC now owns 2,582 shares of the financial services provider’s stock valued at $501,000 after acquiring an additional 1,337 shares during the period. 84.27% of the stock is owned by institutional investors and hedge funds.

NASDAQ CME traded up $1.45 during mid-day trading on Monday, hitting $204.59. The stock had a trading volume of 891,892 shares, compared to its average volume of 1,174,438. The firm’s 50 day moving average is $203.13 and its 200 day moving average is $205.64. CME Group has a twelve month low of $161.05 and a twelve month high of $224.91. The company has a debt-to-equity ratio of 0.14, a current ratio of 1.04 and a quick ratio of 1.04. The stock has a market capitalization of $73.36 billion, a price-to-earnings ratio of 30.00, a PEG ratio of 4.04 and a beta of 0.17.

The business also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Tuesday, December 10th will be paid a $0.75 dividend. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.47%. The ex-dividend date of this dividend is Monday, December 9th. CME Group’s dividend payout ratio (DPR) is presently 43.99%.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

See Also: Outstanding Shares, Buying and Selling Stocks

Get a free copy of the Zacks research report on CME Group (CME)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2020 BBNS.